Adams Julian Insider Trades

Insider Trading History

Track insider trading activity for Adams Julian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $32.5k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $16.9k 4,100 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21k 4,100 shares
$5.12
$4.11
Gamida Cell
Gamida Cell GMDA
Director
Holding Value $13.9k 423,750 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77k 200,000 shares
$0.39
$0.03
Elicio Therapeutics
Elicio Therapeutics ELTX
Director
Holding Value $16.9k 4,100 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.9k 4,100 shares
$8.26
$4.11
Angion Biomedica
Angion Biomedica ANGN
Director
Holding Value $4.1k 4,100 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 4,100 shares
$100.00
$1.00
Gamida Cell
Gamida Cell GMDA
Director
Holding Value $7.32k 223,750 shares
Last Trade
Oct 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.9k 28,300 shares
$0.85
$0.03
Gamida Cell
Gamida Cell GMDA
Director
Holding Value $1.85k 56,600 shares
Last Trade
Oct 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.9k 56,600 shares
$0.85
$0.03
Angion Biomedica
Angion Biomedica ANGN
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2023 Sale
$4.91M 49,144 shares
$100.00
$1.00
Gamida Cell
Gamida Cell GMDA
Director
Holding Value $7.32k 223,750 shares
Last Trade
Feb 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 56,600 shares
$1.59
$0.03
Gamida Cell
Gamida Cell GMDA
Director
Holding Value $311 9,500 shares
Last Trade
Nov 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17k 9,500 shares
$1.79
$0.03
Gamida Cell
Gamida Cell GMDA
Director
Holding Value $6.39k 195,450 shares
Last Trade
Nov 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.58k 2,000 shares
$1.79
$0.03
Gamida Cell
Gamida Cell GMDA
Chief Executive Officer
Holding Value $4.08k 124,650 shares
Last Trade
Jul 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.6k 48,500 shares
$1.60
$0.03
Gamida Cell
Gamida Cell GMDA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2022 Sale
$152k 60,000 shares
$2.54
$0.03
Gamida Cell
Gamida Cell GMDA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2022 Sale
$472k 186,000 shares
$2.54
$0.03
Gamida Cell
Gamida Cell GMDA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2022 Sale
$1.52M 596,574 shares
$2.54
$0.03
Gamida Cell
Gamida Cell GMDA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2022 Sale
$351k 138,000 shares
$2.54
$0.03
Gamida Cell
Gamida Cell GMDA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2022 Sale
$351k 138,000 shares
$2.54
$0.03
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.4M 20,000 shares
$617.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22M 20,000 shares
$160.80
$13.60
Infinity Pharmaceuticals
Infinity Pharmaceuticals INFI
President Of R&d
Holding Value $473 59,150 shares
Last Trade
Oct 31, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.6k 59,150 shares
$1.21
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up